Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series A

Mogrify develops $16m series A
Ahren Innovation Capital has led a $16m initial series A tranche for Mogrify, co-founded by researchers from Bristol, Monash and Duke universities.
IM Therapeutics seizes $10m series A
University of Colorado-founded IM Therapeutics has received $10m from investors including the university's Healthcare Innovation Fund to advance a treatment for type 1 diabetes.
MiroBio signals for $33.1m
University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.
Icosavax applies $51m series A
Icosavax has launched out of University of Washington with $51m in series A funding to move a vaccine for respiratory syncytial virus into a phase 1b trial.
Daily deal net: October 3, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
ZielBio reaches $25.1m series A target
Partners HealthCare has co-led a series A round for ZielBio to drive forward the development of a cancer treatment based on research at University of Virginia.
Daily deal net: September 27, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Meissa synthesises $30m series A
Morningside Ventures has led a $30m series A round for Emory University spinout Meissa Vaccines, a current resident in Johnson & Johnsons’ JLabs incubator.

Other News

Denteric inspects $14m
Gum disease vaccine developer Denteric has spun out of Melbourne with series A capital from the institution, the Biomedical Translation Fund and CSL.
Curamir curates $10m
Curamir Therapeutics, a cancer therapeutics developer exploiting Suny research into microRNA, has made its formal debut with $10m of series A funding.
Vision Medicals digs in for $14m
Cash Capital co-led a series A for Vision Medicals, co-founded by faculty at the Yunnan Province Key Laboratory for Gene Editing.
Daily deal net: September 13, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: September 10, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
PBG plates up $26m series A1
Harvard spinout Platelet BioGenesis has added $26m in series A1 financing to its coffers thanks to a consortium co-led by Ziff Capital Partners and Qiming Venture Partners USA.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Sphere Fluidics circles $2.5m
test reg

Login